Moreover, USP22 can be transcriptionally upregulated by HIF1α, creating a positive feedback loop that amplifies stemness characteristics and reduces the sensitivity of HCC cells to sorafenib [165]. The gene discussed is USP22; the disease is hepatocellular carcinoma.